Bullzeye FinancialIndegene Ltd.
NSE: INDGN · Healthcare
Strong Q1 revenue growth (39.7% YoY) and 12-month outperformance vs NIFTY (+12.59%) support momentum, but valuation unknowns and peak…
Q1 FY27 confirmed 39.7% YoY revenue growth with 10.64% net margin, plus 12.59% relative strength over 12 months despite NIFTY declining 8.64%, indicates stock-specific fundamental strength beyond sentiment.
Stock trades 0.44% below 52-week high after 43.79% six-month rally with no valuation metrics available; RSI at 64.28 approaching overbought and 2.87x volume spike suggest momentum-driven buying vulnerable to reversal.
Free: 5 Forecasts and 5 Debates a month. Log in with your mobile number.
-
Bullish 28 Sep 2026 → now Scores 28 Oct 2026₹613.30 → ₹613.30 0.0%
Every verdict and forecast here is dated and scored when it matures — right or wrong. The first scored results publish a month after launch.
How we score →